NCT00954122View on ClinicalTrials.gov

Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

April 30, 2010

Conditions
Schizophrenia
Interventions
DRUG

Quetiapine XR (Seroquel XR)

Tablet, oral, once daily

Trial Locations (2)

Unknown

Research Site, Johor Bahru

Research Site, Kuala Lumpur

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY